| Cancer in 15-to 29-year-olds by primary site A Bleyer, A Viny, R Barr The oncologist 11 (6), 590-601, 2006 | 354 | 2006 |
| Single-cell mutation analysis of clonal evolution in myeloid malignancies LA Miles, RL Bowman, TR Merlinsky, IS Csete, AT Ooi, ... Nature 587 (7834), 477-482, 2020 | 352 | 2020 |
| Genetic alterations of the cohesin complex genes in myeloid malignancies S Thota, AD Viny, H Makishima, B Spitzer, T Radivoyevitch, ... | 273 | 2014 |
| DNA methylation disruption reshapes the hematopoietic differentiation landscape F Izzo, SC Lee, A Poran, R Chaligne, F Gaiti, B Gross, RR Murali, ... Nature genetics 52 (4), 378-387, 2020 | 206 | 2020 |
| Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis AD Viny, CJ Ott, B Spitzer, M Rivas, C Meydan, E Papalexi, D Yelin, ... Journal of Experimental Medicine 212 (11), 1819-1832, 2015 | 156 | 2015 |
| Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma JM Kahn, THM Keegan, L Tao, R Abrahão, A Bleyer, AD Viny Cancer 122 (17), 2723-2730, 2016 | 139 | 2016 |
| A multiplexed system for quantitative comparisons of chromatin landscapes P van Galen, AD Viny, O Ram, RJH Ryan, MJ Cotton, L Donohue, ... Molecular cell 61 (1), 170-180, 2016 | 129 | 2016 |
| Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML M Stahl, K Menghrajani, A Derkach, A Chan, W Xiao, J Glass, AC King, ... Blood advances 5 (5), 1552-1564, 2021 | 123 | 2021 |
| Cohesin members Stag1 and Stag2 display distinct roles in chromatin accessibility and topological control of HSC self-renewal and differentiation AD Viny, RL Bowman, Y Liu, VP Lavallée, SE Eisman, W Xiao, ... Cell stem cell 25 (5), 682-696. e8, 2019 | 115 | 2019 |
| Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms RJ Molenaar, S Thota, Y Nagata, B Patel, M Clemente, B Przychodzen, ... Leukemia 29 (11), 2134-2142, 2015 | 104 | 2015 |
| Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia AD Viny, A Lichtin, B Pohlman, T Loughran, J Maciejewski Leukemia & lymphoma 49 (5), 932-938, 2008 | 98 | 2008 |
| Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia MJ Clemente, MW Wlodarski, H Makishima, AD Viny, I Bretschneider, ... Blood, The Journal of the American Society of Hematology 118 (16), 4384-4393, 2011 | 90 | 2011 |
| Subtype-specific 3D genome alteration in acute myeloid leukaemia J Xu, F Song, H Lyu, M Kobayashi, B Zhang, Z Zhao, Y Hou, X Wang, ... Nature 611 (7935), 387-398, 2022 | 73 | 2022 |
| Driver mutations in acute myeloid leukemia A Kishtagari, RL Levine, AD Viny Current opinion in hematology 27 (2), 49-57, 2020 | 71 | 2020 |
| Genetics of myeloproliferative neoplasms AD Viny, RL Levine The Cancer Journal 20 (1), 61-65, 2014 | 67 | 2014 |
| Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia V Subbiah, AD Viny, S Rosenblatt, B Pohlman, A Lichtin, JP Maciejewski Experimental hematology 36 (9), 1078-1083, 2008 | 67 | 2008 |
| PRMT5 Inhibition Modulates E2F1 Methylation and Gene-Regulatory Networks Leading to Therapeutic Efficacy in JAK2V617F-Mutant MPN F Pastore, N Bhagwat, A Pastore, A Radzisheuskaya, A Karzai, ... Cancer discovery 10 (11), 1742-1757, 2020 | 58 | 2020 |
| Hemorrhagic complications associated with dabigatran use BC Chen, AD Viny, FM Garlich, P Basciano, MA Howland, SW Smith, ... Clinical toxicology 50 (9), 854-857, 2012 | 58 | 2012 |
| The impact of inflammation-induced tumor plasticity during myeloid transformation A Yeaton, G Cayanan, S Loghavi, I Dolgalev, EM Leddin, CE Loo, ... Cancer discovery 12 (10), 2392-2413, 2022 | 36 | 2022 |
| Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia BM Barth, W Wang, PT Toran, TE Fox, C Annageldiyev, RM Ondrasik, ... Blood advances 3 (17), 2598-2603, 2019 | 33 | 2019 |
